SearchDictionaryMobileLogin

K Itoh Selected Research

Antigens

04/2004Analysis of cellular localization of SART3 tumor antigen by a newly established monoclonal antibody: heterotopic expression of SART3 on the surface of B-lineage leukemic cells.
04/2002Non-mutated tumor-rejection antigen peptides elicit type-I allergy in the majority of healthy individuals.
09/2001Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation.
09/2001Multidrug resistance-associated protein 3 is a tumor rejection antigen recognized by HLA-A2402-restricted cytotoxic T lymphocytes.
05/2001Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides.
04/2001Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients.
04/2001[Cancer vaccine with peptides derived from tumor rejection antigens]
03/2001Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas.
02/2001Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases.
12/2000Expression of the SART1 tumor-rejection antigens in colorectal cancers.
12/2000Expression of the SART3 tumor rejection antigen in renal cell carcinoma.
11/2000Expression of tumor-rejection antigens in gynecologic cancers.
09/2000[Human tumor-rejection antigens and peptides from genes to clinical research]
09/2000Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides.
09/2000A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma.
07/2000Expression of the SART1 tumor-rejection antigen in human osteosarcomas.
06/2000Expression of the SART1 tumor rejection antigen in renal cell carcinoma.
05/2000Induction of human leukocyte antigen-A26-restricted and tumor-specific cytotoxic T lymphocytes by a single peptide of the SART1 antigen in patients with cancer with different A26 subtypes.
03/2000Expression of SART3 tumor-rejection antigen in gastric cancers.
02/2000Mouse homologue of the human SART3 gene encoding tumor-rejection antigen.

Articles by Research Topic

Disease

35Neoplasms (Cancer)
12/2007 - 02/2000
6Colorectal Neoplasms (Colorectal Cancer)
04/2004 - 10/2000
5Breast Neoplasms (Breast Cancer)
08/2001 - 01/2000
5Hepatocellular Carcinoma (Hepatoma)
03/2001 - 01/2000
4Neoplasm Metastasis (Metastasis)
10/2001 - 02/2000
4Renal Cell Carcinoma (Grawitz Tumor)
09/2001 - 06/2000
3Colitis
05/2006 - 04/2000
3Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2002 - 08/2000
2Brain Neoplasms (Brain Tumor)
10/2002 - 09/2000
2Lymphoma (Lymphomas)
03/2002 - 08/2000
2Rheumatoid Arthritis
02/2001 - 10/2000
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
07/2007
1Chronic Kidney Failure (Chronic Renal Failure)
11/2005
1Small Cell Carcinoma
10/2005
1Fabry Disease (Fabry's Disease)
10/2005
1Secondary Hyperparathyroidism
07/2005
1Gastroesophageal Reflux (GERD)
06/2005
1Severe Acute Respiratory Syndrome
11/2004
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2004
1Septic Shock (Toxic Shock Syndrome)
01/2004
1Seizures (Seizure)
01/2004
1Hyperthyroidism
12/2003
1Shock
09/2003
1Atopic Dermatitis (Atopic Eczema)
05/2003
1Hypersensitivity (Allergy)
04/2002
1Cerebral Malaria
12/2001
1Testicular Neoplasms (Testicular Cancer)
11/2001
1Prostatic Neoplasms (Prostate Cancer)
10/2001
1Carcinoma (Carcinomatosis)
08/2001
1Heterotopic Ossification (Ectopic Ossification)
08/2001
1Pain (Aches)
06/2001
1Myocardial Infarction
12/2000
1Esophageal Neoplasms (Esophageal Cancer)
12/2000
1Infection
11/2000
1Uveitis
10/2000

Drug/Important Bio-Agent (IBA)

20AntigensIBA
04/2004 - 02/2000
13PeptidesIBA
12/2007 - 09/2000
2Dextrans (Dextran)FDA Link
05/2006 - 04/2000
2SodiumIBA
05/2006 - 04/2000
2EpitopesIBA
09/2003 - 05/2003
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2002 - 10/2000
2lenograstimIBA
09/2002 - 08/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2001 - 05/2000
2docetaxel (Taxotere)FDA Link
08/2001 - 10/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2001 - 10/2000
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2001 - 04/2000
21,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
03/2001 - 10/2000
2Ethanol (Ethyl Alcohol)IBA
05/2000 - 02/2000
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
07/2007
1Estradiol (Estrace)FDA LinkGeneric
11/2005
1gemcitabineFDA Link
10/2005
1alpha-Galactosidase (Beano)IBA
10/2005
1Parathyroid Hormone (Parathormone)IBA
07/2005
1Omeprazole (Esomeprazole)FDA LinkGeneric
06/2005
1Famotidine (Pepcid)FDA LinkGeneric
06/2005
1rituximab (Mabthera)FDA Link
05/2004
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
04/2004
1Subunit VaccinesIBA
04/2004
1Pentylenetetrazole (Metrazol)IBA
01/2004
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2004
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2004
1Adenosine Triphosphatases (ATPase)IBA
12/2003
1Immunoglobulin G (IgG)IBA
05/2003
1AutoantigensIBA
05/2003
1ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA
10/2002
1Interleukin-2 (IL2)IBA
03/2002
1Thymidine KinaseIBA
03/2002
1CD40 Ligand (CD40L)IBA
11/2001
1prostatic acid phosphataseIBA
10/2001
1RNA Precursors (Precursor, mRNA)IBA
09/2001
1GadoliniumIBA
09/2001
1multidrug resistance-associated protein 3IBA
09/2001
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
08/2001
1irinotecan (Camptosar)FDA LinkGeneric
08/2001
1cyclophilin BIBA
07/2001
1EnzymesIBA
02/2001
1Transcription Factors (Transcription Factor)IBA
02/2001
1ferumoxides (Feridex)FDA Link
02/2001
1Serum Amyloid A Protein (Serum Amyloid A)IBA
02/2001
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2001
1UbiquitinIBA
12/2000
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2000
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2000
1HLA-A2 Antigen (HLA A2 Antigen)IBA
11/2000
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
10/2000
1pectinIBA
10/2000
1Fas Ligand Protein (Fas Ligand)IBA
10/2000
1Sulfalene (Longum)IBA
10/2000
1GuanosineIBA
09/2000

Therapy/Procedure

1Combination Drug Therapy (Combination Chemotherapy)
10/2005
1Renal Dialysis (Hemodialysis)
10/2005
1Parathyroidectomy
07/2005
1Thoracotomy
06/2004
1Kidney Transplantation
01/2004
1Drug Therapy (Chemotherapy)
11/2001
1Transplants (Transplant)
09/2001
1Oral Surgery (Maxillofacial Surgery)
06/2001
1Immunotherapy
12/2000
1Hepatectomy
11/2000
1Liver Transplantation
11/2000